PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany.\', \'Testing Laboratory for In-vitro Diagnostic Medical Devices, Paul-Ehrlich-Institute, Langen, Germany.\', \'Charité - Universitätsmedizin Berlin, Institute of Virology and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany.\', \'Labor Berlin, Charité - Vivantes GmbH, Berlin, Germany.\', \'Bundeswehr Institute of Microbiology and German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany.\', \'LADR Central Laboratory Dr. Kramer & Colleagues, Geesthacht, Germany.\', \'MVZ Labor28 GmbH, Berlin, Germany.\', \'Bernhard Nocht Institute for Tropical Medicine, Arbovirology Department, Hamburg, Germany.\', \'Department of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, Rostock, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2021.26.44.2100442
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34738516
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all